The Wireless PDT Implant market comprises miniaturized, battery‑free photodynamic therapy devices that are implanted and powered remotely to deliver targeted light activation for oncologic and ophthalmic indications. Its relevance stems from the ability to provide minimally invasive, outpatient‑focused cancer treatment while eliminating the need for surgical battery replacements. The market overview highlights the Wireless PDT Implant market size, growth outlook, market forecast, and industry expansion, covering device types, applications, and end‑users worldwide. In 2025, the market was valued at approximately $85 million, and it is projected to expand at a compound annual growth rate (CAGR) of 12% from 2026 to 2033, reaching close to $180 million by the end of the forecast horizon.